Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States
Go back to Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States| (AMEX: ACHFF) | Delayed: 0.65 +0.03 (4.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $ | |||
| Open | $0.67 | 52 Week Low | $ | |||
| Day High | $0.68 | P/E | N/A | |||
| Day Low | $0.65 | EPS | $ | |||
| Volume | 11,500 | |||||
| (NYSE: ARCH) | Delayed: 134.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $134.83 | 52 Week High | $86.47 | |||
| Open | $134.83 | 52 Week Low | $59.05 | |||
| Day High | $134.83 | P/E | N/A | |||
| Day Low | $134.83 | EPS | $0.00 | |||
| Volume | 408 | |||||
